BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

GLP-1R–GIPR–PPARα/γ/δ quintuple agonist reverses obesity and diabetes

BC Staff
June 2, 2026 11:36 PM UTC

BCIQ Target Profiles

Gastric inhibitory polypeptide receptor (GIPR)

Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R)

Peroxisome proliferation activated receptor (PPAR) alpha

Peroxisome proliferation activated receptor (PPAR) delta

Peroxisome proliferation activated receptor (PPAR) gamma

BCIQ Target Profiles

Gastric inhibitory polypeptide receptor (GIPR)

Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R)

Peroxisome proliferation activated receptor (PPAR) alpha

Peroxisome proliferation activated receptor (PPAR) delta

Peroxisome proliferation activated receptor (PPAR) gamma

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2026 BioCentury Inc. All Rights Reserved.
Copyright © 2026 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS